amobarbital has been researched along with American Trypanosomiasis in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Titto, EH | 1 |
| Cardoni, RL | 2 |
| Rimoldi, MT | 1 |
| de Bracco, MM | 1 |
2 other studies available for amobarbital and American Trypanosomiasis
| Article | Year |
|---|---|
Trypanosoma cruzi: parasite-induced release of lysosomal enzymes by human polymorphonuclear leukocytes.
Topics: Amobarbital; Azides; Chagas Disease; Cyanides; Cytochalasin B; Glucuronidase; Humans; Muramidase; Ne | 1983 |
Antibody-dependent cytotoxicity of human and mouse mononuclear cells against Trypanosoma cruzi epimastigotes.
Topics: Amitrole; Amobarbital; Animals; Antibody-Dependent Cell Cytotoxicity; Azides; Cell Adhesion; Chagas | 1984 |